This is a non-therapeutic clinical trial that is only open to St. Jude patients.
St. Jude patients who are at least one year from their hematopoietic stem cell transplantation will be asked to return to St. Jude once a year for a general check-up. During this visit the participant will be asked to answer a short set of questions and the doctor will do a complete physical exam.Blood and x-ray work will be done to screen for late effects related to hematopoietic stem cell transplant (HSCT). These exams and tests are normally done as routine patient care.
- To provide continuing review of long-term outcomes and adverse events among hematopoietic stem cell recipients monitored by the bone marrow transplant annual follow-up clinic and tumor registry
- St. Jude Children's Research Hospital patient actively monitored in the bone marrow transplant annual follow-up clinic after receiving hematopoietic stem cell (HSC) transplant for a malignant or non-malignant condition
- St. Jude Children’s Research Hospital alumnus monitored by the tumor registry after hematopoietic stem cell transplantation for a malignant or non-malignant condition
- Patient has not been permanently discharged from care and follow-up
Christine Hartford, MD
St. Jude Children’s Research Hospital
262 Danny Thomas Place
Memphis, TN 38105 USA
Voice: 1-888-226-4343 or 901-595-4055
24-Hour Emergency Access Pager: 1-800-349-4334
The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.